Oncology Clinical Trials in Scarborough, ME
As of August 2026, 48 paid clinical trials are recruiting for Oncology in Scarborough, Maine. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
48 clinical trials for Oncology
·Clear filters·A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Endometrial Cancer Vaginal Fluid Specimen Collection Study
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Top Research Study Locations in Scarborough
Researchers run research studies in Scarborough, ME at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MaineHealth Maine Medical Center- Scarborough | Acute Myeloid Leukemia, Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm | 42 |
| Maine Children's Cancer Program | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular | 25 |
| New England Cancer Specialists | Breast Cancer, HER2-positive Breast Cancer, Chronic Lymphocytic Leukemia | 6 |
| Maine Medical Center - Scarborough Campus | Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms | 3 |
| MaineHealth | Abnormal Uterine Bleeding (AUB), Atypical Endometrial Hyperplasia, Endometrial Cancer | 2 |
| Maine Medical Center Research Institute-MaineHealth/Maine Medical Partners - GynOnc | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer | 2 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Local Institution - 0127 | Metastatic Non-small Cell Lung Cancer With MTAP Deletion | 1 |
| MMP Neurology | Focal Epilepsy, Tonic-Clonic Seizures | 1 |
| Maine Center For Cancer Medicine | Ovarian Cancer | 1 |
| Maine Health Cardiology | Cardiovascular Disease and Lipoprotein(a) | 1 |
| Maine Hemophilia and Thrombosis Center | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 1 |
| Maine Medical Center | Locally Advanced Solid Tumors, Lymphoma, Metastatic Solid Tumors | 1 |
| Maine Medical Center- Scarborough Campus | Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | 1 |
| Maine Medical Partner's Women's Health | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
| Maine Medical Partners MaineHealth Cardiology | Atrial Fibrillation | 1 |
| Maine Medical Partners-Woman's Health-Division of Gynecologic Oncology | Cervical Cancer | 1 |
| MaineHealth Cancer Care | Extensive Stage Small Cell Lung Cancer (ES-SCLC) | 1 |
| MaineHealth Cancer Care - Scarborough | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| MaineHealth Cancer Care and Blood Disorders Scarborough | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| MaineHealth Cardiology | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| MaineHealth Center for Clinical and Translational Science | Drug Effect, Musculoskeletal Abnormalities, Obesity | 1 |
| MaineHealth Neurosurgery and Spine | Degenerative Disc Disease, Degenerative Scoliosis | 1 |
| MaineHealth Pediatric Neurology | Headache, Migraine | 1 |
| MaineMed Vascular Surgery | Abdominal Aortic Aneurysm | 1 |
Active & Upcoming Studies in Scarborough (2026)
Recruiting trials in Scarborough grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (69 active studies)
- A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment · Phase 2 · Alliance for Clinical Trials in Oncology
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
Diabetes & metabolic (2 active studies)
- GLP-1R Actions on Muscle and the Skeleton · Phase 4 · Pennington Biomedical Research Center
- A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma · Phase 2 · Children's Oncology Group
Neurology & pain (2 active studies)
- Adolescent Lifestyle Medicine Headache Study · MaineHealth
- An Open-label Study of XEN1101 in Epilepsy · Phase 3 · Xenon Pharmaceuticals Inc.
Vaccines (1 active study)
Cardiovascular (1 active study)
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation · Phase 3 · Johns Hopkins University
Common conditions studied in Scarborough
- Acute Myeloid Leukemia (9 active studies)
- Breast Cancer (5 active studies)
- Malignant Solid Neoplasm (5 active studies)
- Ovarian Cancer (5 active studies)
- Endometrial Cancer (4 active studies)
- Lung Non-Small Cell Carcinoma (4 active studies)
Leading research sponsors in Scarborough
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Wake Forest University Health Sciences
Frequently asked questions
How many paid clinical trials are currently recruiting in Scarborough?
There are approximately 97 recruiting clinical trials in Scarborough, Maine listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Scarborough pay participants?
Most recruiting trials in Scarborough compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Scarborough?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Scarborough?
The most common conditions under active study in Scarborough include Acute Myeloid Leukemia (9), Breast Cancer (5), Malignant Solid Neoplasm (5), Ovarian Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Scarborough?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Scarborough on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Scarborough?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Scarborough?
Recruiting research sites in Scarborough include MaineHealth Maine Medical Center- Scarborough, Maine Children's Cancer Program, New England Cancer Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Scarborough right now?
The largest active categories in Scarborough are Cancer & tumors (69), Diabetes & metabolic (2), Neurology & pain (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.